Baker, Justin T.
Germine, Laura T.
Ressler, Kerry J.
Rauch, Scott L.
Carlezon, William A. Jr. http://orcid.org/0000-0002-4162-3947
Article History
Received: 23 May 2018
Revised: 26 July 2018
Accepted: 27 July 2018
First Online: 2 August 2018
Competing interests
: JTB serves as a consultant for Pear Therapeutics and Niraxx Therapeutics, LTG serves as a consultant for 23andme, and KJR is on the Scientific Advisory Board for Resilience Therapeutics and serves as a consultant for Biogen. The other authors declare no competing interests.